Skip to main content

Table 2 Description of the 8 scenarios simulated

From: The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study

Scenario Time to diagnosis (mean) Time to linkage to care (mean) Loss to follow-up rate (%/y) Treatment eligibility Treatment rate among eligible PWID %SVR
1 (reference) 2 y 1.7 y 10.2%/y F0 → F4 5%/y 81%
2 0.5 y 1.7 y 10.2%/y F0 → F4 5%/y 81%
3 2 y 0.5y 5%/y F0 → F4 5%/y 81%
4 2 y 1.7 y 10.2%/y F0 → F4 5%/y 90%
5 2 y 1.7 y 10.2%/y F0 → F4 10%/y 81%
6 2 y 1.7 y 10.2%/y F0 → F4 20%/y 81%
7 0.5 y 0.5 y 5%/y F0 → F4 20%/y 90%
8 0.5 y 0.5 y 5%/y F2 → F4 100%/y 90%
  1. PWID People who inject drugs, SVR sustained virological response